Most Downloaded

    Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

    All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Group Purchasing Organizations (GPOs) in the U.S.: Development and Reform
    Jin Jing, Xiong Jiamei, Yang Yue, Huang Zhe
    Asian Journal of Social Pharmacy    2019, 14 (3): 100-109.  
    Abstract751)      PDF(pc) (2783KB)(5294)       Save
    Objective To study the characteristics, specific functions and policy improvement process of the Group Purchasing Organizations (GPOs) in the U.S. and to provide references for drug group purchasing practices in China. Methods Domestic and foreign relevant literatures, websites were reviewed or searched to analyze the functions and policy improvement process of the GPOs in the U.S. so as to provide references for drug group purchasing practices in China. Results and Conclusion As a third party in the U.S. GPOs has formed a relatively integrated business process and projects service system after long-term development. Supported by corresponding policies and industrial regulations, GPOs have made a great contribution to control the growth of medical and healthcare expenses and improve the efficiency of medical institutions, and its development experience can enlighten the practices in China.
    Related Articles | Metrics | Comments0
    Development of Licensed Pharmacists in China: Dilemma and Opportunity
    De Xianhui, An Lianyu, Wang Shuling
    Asian Journal of Social Pharmacy    2019, 14 (4): 192-203.  
    Abstract507)      PDF(pc) (1418KB)(5170)       Save
    Objective To study the current status of licensed pharmacists in China, and to make suggestions for the sound development of regulation authorities and licensed pharmacists. Methods Literature review and data research were conducted to analyze the status of examinations, registration, academic qualification and professional composition of licensed pharmacists. And SWOT method was used to analyze the strengths, weaknesses, opportunities and threats for the development of licensed pharmacists. Results and Conclusion Licensed pharmacists have such advantages and opportunities as professionalism, favorable policies, and continuous expansion of market demand. However, they also face disadvantages and threats, such as low service capacity, weak service awareness and low social status. According to the results of SWOT analysis, it is suggested that the government should make use of the advantages of artificial intelligence to build a regulatory information platform and a public platform for electronic prescriptions. Meanwhile, a national accreditation agency for continuing education should be established, and academic exchanges between regional licensed pharmacists and physicians must be organized regularly. Besides, licensed pharmacists can use mobile phones and other information devices to keep abreast of national policy and new medical information. Therefore, their services will be recognized by the public, thus to protect the drug safety for the public.
    Related Articles | Metrics | Comments0
    The Status Quo and Countermeasures of “4+7” Quantity Purchase in China
    Zhou Yusheng, Wei Xingchen, Piao Huiling, Wang Nan, Wang Xing, Dong Li
    Asian Journal of Social Pharmacy    2020, 15 (2): 89-96.  
    Abstract507)      PDF(pc) (803KB)(4487)       Save
    Objective To understand the effectiveness and problems of centralized drug procurement in China by analyzing the implementation of the “4+7” pilot work for centralized drug procurement in China. Methods The current situation and existing problems of drug procurement in China were analyzed through the literature research method. Results and Conclusion At present, good social benefits have been achieved for China’s drug procurement through pilot projects in several cities, but there are some serious problems. The proposed countermeasures will help to improve the procurement of pharmaceuticals in China.
    Related Articles | Metrics | Comments0
    Analysis of 4,562 Cases of Adverse Drug Reaction/Event Caused by Cefoperazone Sodium and Sulbactam Sodium for Injection
    Wei Fenfang, Zhang Zhongyi, Zheng Yongxia, Yang Yue
    Asina Journal Of Social Pharmacy   
    Measures to Speed up Drug Review Process in Japan and Its Implications
    Shi Wenwen, Sun Lihua
    Asina Journal Of Social Pharmacy   
    Project Management of Generic Drug R&D and Registration in the United States
    Mao Xiaofang, Qi Xiang, Zhou Fengxiang
    Asina Journal Of Social Pharmacy   
    Research on Incentive Policies for Chinese Innovative Drug R&D - Taking Innovative Anti-tumor Drugs as an Example
    Wang Yuejun, Yang Yue, Huang Zhe
    Asian Journal of Social Pharmacy    2023, 18 (4): 303-314.  
    Abstract186)      PDF(pc) (2658KB)(1713)       Save
    Objective To provide reference for improving Chinese innovative drug research and development incentive policies. Methods Based on investigating the incentive policies for innovative drug research and development in clinical research, evaluation and approval in China, anti-tumor drugs were taken as the research object to discuss relevant policies from the perspective of clinical trials and registration approval based on data statistics and current situation analysis. Results and Conclusion Driven by a series of incentive policies for innovative drug R&D, great achievements have been made on anti-tumor drugs. However, there are problems such as concentration of drug targets, homogenization of clinical trials, and gaps in some drugs with large clinical needs. To improve incentive policies for innovative drug R&D, China should adhere to the orientation of clinical value, focusing on basic research and translational research, improving evaluation and approval capabilities, and establishing a sound ecosystem for innovative drugs.
    Related Articles | Metrics | Comments0
    Current Situation and Development Strategy of Residents’ Cognition and Use of TCM in Liaoning Province
    Wang Shuling, Ren Zhaoxia, He Yalan
    Asian Journal of Social Pharmacy    2021, 16 (2): 163-173.  
    Abstract500)      PDF(pc) (4509KB)(1632)       Save

    Objective To investigate and analyze the residents’ cognition and use of traditional Chinese medicine (TCM) and put forward corresponding countermeasures for its existing problems. Methods A questionnaire survey was conducted to investigate the cognition and trust of TCM from 380 residents in Liaoning Province. Then, the differences of residents’ way of purchasing TCM and gaining the knowledge of TCM. Finally, Polygonum multiflorum was taken as an example to analyze the problems in residents’ cognition and use of Chinese medicinal materials, Chinese traditional decoction pieces, and Chinese patent medicine. Results and Conclusion A total of 402 questionnaires were collected, and 380 were valid. The effective rate was 94.53%. Residents’ understanding of the top three TCM processing techniques were simmering (58.95%), baking (56.84%), and parching (45.00%). The top three best-known TCM for them were chrysanthemum (72.63%), tangerine peel (63.16%), and hawthorn (62.11%). The main factors influencing residents’ willingness to purchase TCM were doctors’ advice (52.63%), and experts or experienced people’s suggestion (54.21%). The top three ways of residents’ gaining TCM knowledge were: TCM knowledge lecture (64.21%), health care knowledge (55.79%), and personal experience of Chinese medicine such as acupuncture and cupping (54.21%). However, due to the lack of professional knowledge of TCM, insufficient supervision and inconsistent standards, residents frequently took TCM by mistake. Residents have a high recognition of TCM, so its future development is optimistic. However, some residents’ insufficient knowledge of TCM often leads to the misapplication of the medicine. Therefore, to improve residents’ cognition of

    TCM, it is not only to actively publicize the professional knowledge of TCM, but also to improve the professional skills of practitioners, and the supervision standards and intensity of TCM market, so as to make residents feel at ease to buy safe and high-quality TCM products.

    Related Articles | Metrics | Comments0
    Research on the Status Quo and Optimization of Centralized Procurement of Coronary Stents
    Zhang Yuting, Liu Xiaoxi
    Asian Journal of Social Pharmacy    2024, 19 (1): 20-28.  
    Abstract173)      PDF(pc) (433KB)(1541)       Save
    Objective To study the impact of the first national centralized procurement of coronary stents on patients’ psychology, the economy of medical institutions, and the survival and development of the coronary stents industry, and to provide suggestions on perfecting procedures to better carry out the centralized procurement of coronary stents. Methods Literature analysis was used to investigate the results of the procurement of coronary stent in a province and a hospital. Results and Conclusion The centralized procurement of coronary stents has alleviated the economic pressure of patients, but it has many problems. Therefore, this paper proposes some suggestions, such as promoting the orderly development of the coronary stent industry, improving the evaluation link of the centralized procurement of coronary stents, adopting the accurate reporting model to ensure the quality of coronary stents and improving the standardization of clinical services.
    Related Articles | Metrics | Comments0
    Application of SWOT Analysis and Porter’s Five Forces Analysis to State-owned Enterprise Affiliated Hospitals in China
    Wang Tao, Wu Zhi’ang, Li Shuchuen
    Asina Journal Of Social Pharmacy   
    The Future Trends of China’s Pharmaceutical Regulation
    SUN Li-hua;LIU Yan;TAO Hai-ying
       2008, 3 (1): 1-4.  
    Abstract2932)            Save
    Objective To provide suggestions on the macro decision-making to pharmaceutical enterprises in China for their healthy development. Methods The future trends of pharmaceutical regulation in China were analyzed using a systematic perspective and methods. Results and Conclusion The future trends of pharmaceutical regulation will be increasingly scientific and rational, and the regulation objectives and key elements will be gradually clear. Pharmaceutical enterprises should be running in line with the development trends of our country as soon as possible.
    Related Articles | Metrics | Comments0
    Strategic Research on Pharmaceutical Enterprises’Participation in National Drug Centralized Procurement
    Yang Dianzheng, Xu Wenxiu, Qi Yun, Yang Yue
    Asian Journal of Social Pharmacy    2022, 17 (1): 15-22.  
    Abstract520)      PDF(pc) (958KB)(1369)       Save
    Objective To study the influence of national drug centralized procurement policy on pharmaceutical enterprises manufacturing generic drugs and original drugs, so as to provide a reference for them to make different strategic choices. Methods Through the literature research on the related policies and the bidding data, the national drug centralized policies were studied systematically. Combined with the bid-winning price and price reduction range of the winning enterprises in the three rounds of centralized procurement, their difficulties, strategic choices and the winning factors were investigated. Besides, a model was established to clarify the optimal price of enterprises in the process of drug procurement. Results and Conclusion The strategic choices of enterprises in participating national drug centralized procurement are influenced by many factors such as the market share of the original varieties, active pharmaceutical ingredients (APIs) and cost. Therefore, corresponding strategies should be formulated according to the characteristics and interests of enterprises.
    Related Articles | Metrics | Comments0
    Dynamic Evaluation on Scientific and Technological Innovation Efficiency of Medical Universities in China
    Tan Xiaodong, Chen Yuwen
    Asina Journal Of Social Pharmacy   
    Discussion on the Patent Linkage Problems in Drug Registration
    SHEN Han;XU Huai-fu
       2008, 3 (1): 15-19.  
    Abstract2851)            Save
    Objective To improve the patent linkage system for drug registration in China. Methods The problems in patent linkage and the underlying reasons for the problems in drug registration were analyzed based on the relevant items in the new version of Regulatory Methods for Drug Registration, and comparative analysis of the laws between China and USA was conducted. Results and Conclusion The protection of new drug patents was strengthened by the new Regulative Methods; however, there were still some problems in patent linkage which should be continuously refined by establishing drug patent database. Future research is warranted to investigate the feasibility and operationability of the patent linkage system for the registration of pharmaceutical products in China.
    Related Articles | Metrics | Comments0
    The Selection of Chinese Pharmaceutical Company’s Strategic Alliance Forms
    GUO Ying;LIU Jiao-yan;GUO Jing;YANG Liang
       2006, 1 (2): 76-79.  
    Abstract2838)            Save
    Objective To probe into the suitable strategic alliance forms of our country for the present by describing the current overall strategic alliance forms. Methods Based on the profound study carried out in literature method, we draw lessons from the foreign strategic alliance and put forward the suitable forms of our country. Results and Conclusion The pharmaceutical company should adopt different strategic alliance according to the different types.
    Related Articles | Metrics | Comments0
    Analysis of Factors Affecting Online Drug Purchase – Based on Factor Analysis
    Wang Shuling, Liu Liang, Zhi Yuanyuan
    Asian Journal of Social Pharmacy    2022, 17 (3): 268-280.  
    Abstract377)      PDF(pc) (2843KB)(1322)       Save
    Objective To explore the factors affecting consumers’ online drug purchases, and construct models of these factors to provide references for the development and popularization of online pharmacies. Methods Through searching, classifying, integrating, and extracting evaluation indexes of online pharmacies in literature, the indexes of factors affecting online drug purchases were initially established. Then SPSS24.0 was used for data analysis, and finally factor analysis was applied for screening and combining the indexes. Results and Conclusion A model of influencing factors for online drug purchases is set up with 4 factors and 14 indexes. Convenient service is the most important factor affecting online drug purchases. Highly educated young people prefer to buy drugs online. At present, online drug purchase is only a supplement to the purchase of drugs in offline pharmacies, and the penetration rate is not high. Online pharmacies should give full play to their advantages in terms of drug types, prices, logistics and after-sales services to make online drug purchases more mainstream.
    Related Articles | Metrics | Comments0
    Present Situation and Enlightenment of Post-Approval Change Management of Drugs in China, USA and EU
    Lv Xiaowen, Huang Zhe
    Asian Journal of Social Pharmacy    2023, 18 (1): 17-23.  
    Abstract492)      PDF(pc) (358KB)(1315)       Save
    Objective To provide suggestions for further improvement of China’s drug post-approval change management system. Methods The current legal and regulatory requirements of post-approval change management systems of drugs in USA, EU and China were compared and analyzed. Results and Conclusion The post-approval change management of drugs is an important part of the whole life-cycle management of drugs. However, there are still some problems in China’s current post-approval change management systems. According to the model and requirements of the post-approval change management systems of the USA and EU, this paper proposes the following suggestions for the improvement of China’s post-approval change management system. Firstly, electronic files for licensed products should be created. Then, regulatory standards at the national level must be unified. Lastly, the concept of product life cycle management should be implemented.
    Related Articles | Metrics | Comments0
    How to Improve the Current State of Special Pharmacology English Teaching
    KAN Qi-ming;ZHAO Chun-jie;FU Shou-ting;Zou Li-bo
       2006, 1 (2): 103-105.  
    Abstract2890)            Save
    Objective In order to satisfy the request of special English in pharmaceutical occupation, and to reform the teaching style in special English to need badly, we want to give some suggestion. Methods The teaching style was dry and tasteless to date and the student need to understand the major theory in English step by step. It is indicated how to improve the current state of special English teaching through teaching material selection, teaching style and teaching system. We wish the new way to study special English could stimulate the interest of studying and the student could study in activity. Results and Conclusion It is pharmaceutical teacher’s responsibility and liability to enhance the English level of student and to culture the talented and international person in pharmacy.
    Related Articles | Metrics | Comments0
    The Informationization Construct in Favor of EC in Our Pharmaceutical Enterprises
    ZHOU Ying;CHEN Yu-wen;MENG Ling-quan;SHEN Wei
       2006, 1 (2): 98-102.  
    Abstract385)            Save
    Objective To explore the informationization construct in favor of EC in our pharmaceutical enterprises. Methods Combining practice situation of the informationization construct in our pharmaceutical enterprises, to research the conditions to develop EC favorably. Results and Conclusion The EC’s developing in our pharmaceutical enterprises should form a uniform EC’s transaction flatform, develop and apply the product which accord with the developing of pharmaceutical enterprises in our country, construct the special institution and set the information officer etc.
    Related Articles | Metrics | Comments0
    Analyse and Study on the Problems Exist in the GSP
    JIANG Rong;LIANG Yi
       2006, 1 (2): 80-83.  
    Abstract1825)            Save
    Objective Study and probe into the profound problems exist in the GSP standard system. Methods Analysis the problems in depth in the light of practical GSP. Results and Conclusion The profound problems exist in the GSP standard system exert an influence on the penetrating GSP implement in China and should be corrected and improved.
    Related Articles | Metrics | Comments0
    Research on the Development of the Discipline of Pharmacy Administration
    TIAN Li-juan
       2006, 1 (2): 90-94.  
    Abstract1722)            Save
    Objective To discuss the development process of the discipline of pharmacy administration in China, then give valuable experience and reference on the further development of the discipline of pharmacy administration. Methods Literature research methods. Results and Conclusion Although experienced many setbacks, the discipline of pharmacy administration in China has made unprecedented achievements and showed a thriving scene since the People’s Republic of China was founded.
    Related Articles | Metrics | Comments0
    Considerations on the Quality Standards Reflecting the Characteristics of Compound Preparations of Traditional Chinese Medicine
    Zhao Wei, Wu Zhi’ang
    Asian Journal of Social Pharmacy    2022, 17 (3): 199-203.  
    Abstract281)      PDF(pc) (821KB)(1283)       Save
    Objective To study the current quality standard of traditional Chinese medicine (TCM) and its limitations in China, and encourage enterprises to take more responsibility to promote the development of this industry. Methods Based on the analysis of the status quo and problems of the quality standard system of TCM, the quality control mode, as well as the problems found in the reevaluation after marketing, some suggestions were put forward for adjusting the current quality standard of TCM. Results and Conclusion Through strengthening the quality control of the source, and under the premise of ensuring the safety, effectiveness and stability of TCM, the quality standards of TCM can be improved greatly.
    Related Articles | Metrics | Comments0
    On Loyalty to and Good Reputation of Brands of Pharmaceutical Products
    ZHONG Su-yan;LI Min
       2008, 3 (2): 90-93.  
    Abstract593)            Save
    Objective To discuss the strategies for promoting loyalty to and good reputation of brands of medicinal and pharmaceutical products. Methods Conclusions were drawn through analyzing the effects of brand loyalty and good reputation on pharmaceutical enterprise’s value. Results and Conclusion To improve brand good reputation and loyalty concerns pharmaceutical companies’ long-term interests and development. It is an important approach to improving the competitive advantage of China’s pharmaceutical enterprises.
    Related Articles | Metrics | Comments0
    The Modern Research of Traditional Chinese Medicine and Pharmacy and CAS Theory
    ZHANG Fang;PAN Yan
       2006, 1 (2): 71-75.  
    Abstract2935)            Save
    Objective The complicated problems which the modern research of traditional Chinese medicine and pharmacy relating to belong to complex adaptive system(CAS), such as compound Chinese medicine system and viscera system, ect. But it has not been understand fully. This article emphasize comparing the characteristics of two systems upward with CAS theory, in order to apply CAS theory to supply academic basis to innovate research though of the Modern Research of traditional Chinese medicine and pharmacy. Methods Carry on the contrast research within modern research of the Chinese medicine complicated problem and CAS system characteristic. Results and Conclusion The Chinese medicine exists a great deal of CAS problem in the modern research, can draw lessons from the way of thinking and method of the CAS theories to carry on a research.
    Related Articles | Metrics | Comments0
    The Problems and Solution Proposals of the Motivation Mechanism of Innovation in Medicinal Research and Development in China
    SHI Bo-yan;CHEN Yu-wen;ZHUANG Dan;WANG Ying
       2006, 1 (2): 87-89.  
    Abstract1632)            Save
    Objective The thesis explores the problems of the motivation mechanism of the behavioral individuals involved in the innovation in medicinal research and development in China as a reference for the relevant departments. Methods It analyzes the circumstances of innovational motivation of each behavioral individual involved in the innovation in medicinal research and development by means of motivation mechanism model of technical innovation. Results and Conclusion It lists the motivation factors affecting each behavioral individual and puts forward corresponding improvement proposals to the existing problems.
    Related Articles | Metrics | Comments0
    A Study of the National Essential Drug System of China
    LV Tian;SHAO Rong
       2007, 2 (4): 143-147.  
    Abstract594)            Save
    Abstract: Objective To provide suggestions for establishing and improving the national essential drug system of China. Methods The essential drug system was reviewed and the defects and problems in process of implementing of this system were qualitatively analyzed. Results and Conclusion The national essential drug system of China is still in the early stage. Relevant governmental departments and social organizations need to take effective measures to speed up the establishment of the national essential drug system.
    Related Articles | Metrics | Comments0
    Management of Human Resources in New Drug Research and Development
    XING Hua;LI Ye;YAO Jian-hua;LIU Xiao-ting
       2007, 2 (3): 85-89.  
    Abstract2727)            Save
    Objective To explore strategies for improving the management of the human resources for more successful new drug research and development. Methods Based on a comprehensive literature review, this paper emphatically analyzed the present problems in human resources management in the research and development of new drugs. Results and Conclusion Some strategies and operational solutions are proposed.
    Related Articles | Metrics | Comments0
    Looking Through the “Whopping Medical Expense Scandal” to Study the Function and Status of Hospital Pharmacists in China
    SUN Li-hua;WU Chun-fu
       2006, 1 (2): 64-66.  
    Abstract2697)            Save
    Objective To bring hospital pharmacists’ function into full play, and improve rational use of drug. Methods To compare the status, responsibilities and functions of hospital pharmacists in China with the rational mode of the developed countries, and perform analysis on them. Results and Conclusion Hospital pharmacists in China lack proper legislative status; their function is far from being fully exerted. It is suggested that the Pharmacist Law to be enacted as soon as possible.
    Related Articles | Metrics | Comments0
    Licensed Pharmacist System in China
    HUANG Shi-xi
       2007, 2 (2): 41-44.  
    Abstract2383)            Save
    Objective To review the development and practice of licensed pharmacist system in China and provide ideas for its reform. Method Methods of literature analysis were adopted to describe the history and practice of licensed pharmacist system in China. Results and Conclusion The future of licensed pharmacist system in China is promising. Licensed pharmacists will play a much important role in delivering medication and pharmaceutical care.
    Related Articles | Metrics | Comments0
    Strategies for Cultivating Pharmacy Professionals According to Market Demands
    ZHANG Lin-zhi;ZHAO Hong-ge;LIU Yan
       2007, 2 (2): 76-80.  
    Abstract2767)            Save
    Abstract:Objective This article aims to elaborate the necessity and a few means of cultivating university students according to market demands in the process of higher pharmacy education transformation through analyzing the employment situation of pharmacy graduates. Methods By using statistics and literature, integrating theory with practice and taking the employment and training situation of Shenyang Pharmaceutical University graduates as an example, this article expounded strategies for cultivating professionals according to market demands. Results and Conclusion In order to adapt to the current employment situation and the sustainable development of higher pharmacy education, the competition in job market should always be kept in mind by us, the subject structure of pharmacy education curriculum should be continuously reviewed and adjusted, cooperation between universities and employers should be further strengthened, greater effort should be made on employment development, the environment of full employment should be created, and pharmacy professionals to meet the demands of the market should be cultivated.
    Related Articles | Metrics | Comments0
    Modernization of Traditional Chinese Medicines and Drug Innovation
    WU Zhi-ang;;BI Kai-shun
       2006, 1 (2): 67-70.  
    Abstract2687)            Save
    Objective The article is trying to put forward the comments and suggestions concerning of how to deal the relations of between modernization of Traditional Chinese Medicines and drug innovation under the condition of real world. Methods It is trying to probe the relations between modernization of Traditional Chinese Medicines and drug innovation, and then discusses the essential elements and the relations one another in the system of drug innovation. At the same time, the article addresses the status and roles of drug innovation in the system of modernization of Traditional Chinese Medicines. Results and Conclusion The article advances the basic principle how to deal the relations of both, it is that drug innovation serves for the strategy perspective. According to the basic principle, the article advices when considering how to deal the relations of both, it should be the focus and norm that drug innovation service for modernization of Traditional Chinese Medicines, and that could be used for thinking over and harmonizing the development of both.
    Related Articles | Metrics | Comments0
    The Effect of the Amendments of the Pharmaceutical Affairs Law of Japan on China’s Exterritorial Medicine Commissioning Manufacture
    LIANG Yi
       2007, 2 (3): 110-112.  
    Abstract502)            Save

    Abstract: Objective To explore the feasibility and necessity for China’s pharmaceutical enterprises to conduct exterritorial medicine commissioning manufacture. Methods Compare and analyze the laws and regulations governing medicine commissioning manufacture in China, Japan, and other countries. Results and Conclusion Chinese government and pharmaceutical enterprises should seize the opportunities to improve their capacity in exterritorial medicine commissioning manufacture.

    Related Articles | Metrics | Comments0
    Appling Pharmacoeconomics to Drug Reimbursement Decision-making Process in Canada
    ZHANG Jie
       2006, 1 (2): 84-86.  
    Abstract2816)            Save
    Objective Help us to applying pharmacoeconomics to Chinese medical insurance. Methods Introduce the process of incorporating pharmacoeconomics into drug reimbursement in Ontario. Results and Conclusion Although there is many problem in the incorporating, its application framework and application ideas are worthy of our study and research.
    Related Articles | Metrics | Comments0
    Analysis of Drug Medical Insurance Access Pricing Based on the Perspective of Binary Equilibrium
    Zhang Junjun, Wang Shuling
    Asian Journal of Social Pharmacy    2024, 19 (2): 117-125.  
    Abstract121)      PDF(pc) (882KB)(1213)       Save
    Objective To study the influencing factors in the process of national medical insurance negotiation and drug pricing from the dualistic equilibrium perspective, and to provide reference for the harmonious management of drug pricing in China. Methods Through the literature analysis and policy review, the pricing subject, pricing basis and price control system in the pricing process of medical-accessed medicines were analyzed from the perspective of binary equilibrium and harmonious management. Results and Conclusion It is found that four balances in the drug pricing process, two balances in pricing basis and three balances in price control system need to be considered, respectively. Drug pricing is the key content of national medical insurance access, which is also the hotspot of the policy in the pharmaceutical fields in recent years. Drug pricing not only reflects the value of drugs, but also reflects a lot of top-level designs of binary equilibriums in medical insurance policy. While the rational design of drug pricing requires the joint efforts of the government, pharmaceutical companies and relevant experts to comprehensively consider many equilibriums, so as to improve the relevant systems.
    Related Articles | Metrics | Comments0
    A Comparison of Medicine Methodologies and Cultural Embryology Between China and the West
    ZHANG Fang
       2007, 2 (2): 55-59.  
    Abstract549)            Save
    Abstract:Objective From the perspective of cultural embryology, this paper quests for the reasons for the differences in research methodologies between Chinese and Western medicines. Methods Cultural start embryology comparison and contextualization analysis. Results and Conclusion Because the cultural contexts in which Chinese and Western medicines were generated are substantially different, application of modern research methodologies used by Western medicine to Chinese medicine research may not be appropriate.
    Related Articles | Metrics | Comments0
    Price Comparison between Brand-name Drugs and Generics in China
    XU Li-ping;LI Ye;SHI Lu-wen;GUAN Xiao-dong;HAN Sheng
       2009, 4 (4): 167-170.  
    Abstract2002)            Save

    Abstract

    Objective To provide scientific reference for government price management of brand-name drugs and generics. Methods Price ratio between brand-name drugs and generics under government pricing mode was calculated and price difference between typical therapeutic categories and typical formulations was compared. Results and Conclusion The average price ratio between brand-name drugs and generics is 2.75 times. Only 24% of drugs fall in line with the price difference rate as required by the Governmental Pricing Method for the Pharmaceuticals in China (2000). Price difference between brand-name drugs and generics is wide in China. Pharmacoeconomic evaluation methods could be introduced to improve drug concentrated biding system as well as the reimbursement mechanism, to gradually narrow the price difference between brand-name drugs and generics.

    Related Articles | Metrics | Comments0
    Reconstructing the Existing Information Platform of Electronic Commerce for the Development of On-Line Pharmacy in China
    MENG Ling-quan;ZHOU Ying;XING Hua
       2007, 2 (2): 67-71.  
    Abstract2343)            Save
    Abstract:Objective To explore the development of commercial information platform for running internet drug stores. Methods The existing information platform of electronic commerce was converted into the platform for on-line pharmacy by using the experiences of building the information platform of electronic commerce in out country. Results and Conclusion On-line pharmacy commercial information platform should support the payment system of the social medical treatment and insurance card.
    Related Articles | Metrics | Comments0
    The Development of a Model for Optimizing the Management of Medicinal Logistics
    FU Shu-yong;SUN Shu-jun
       2007, 2 (3): 90-92.  
    Abstract2678)            Save
    Objective To design a model for optimizing the medicinal distribution management. Methods Utilizing the linear programming theory to construct the model. Results and Conclusion The model which can optimize the medicinal distribution management was developed and the ranges for model parameters that can keep the optional result invariable were determined.
    Related Articles | Metrics | Comments0
    Legal Governance of Commercial Bribery in the Pharmaceutical Industry
    LUO Guan-jie
       2007, 2 (4): 148-152.  
    Abstract2968)            Save
    Abstract: Objective To put forward some suggestions on improving the laws governing commercial bribery and to promote the legal governance of commercial bribery in the pharmaceutical industry of China. Methods The characteristics and harm of commercial bribery in pharmaceutical industry and the deficiency of the laws governing commercial bribery were analyzed. Results and Conclusion Commercial bribery in the pharmaceutical industry has three important characteristics. Its harm is so serious that we must regulate it with laws. Many deficiencies existing in the laws make the laws not effective at all. A series of practical suggestions were put forward aiming to improve the laws governing commercial bribery in the pharmaceutical industry of China.
    Related Articles | Metrics | Comments0